• 120 mg urea

• DL-α-tocopherol acetate
• Glycerol 85%
• Vaseline, white
• wheat starch
• Retinol, oily solution
• isopropyl myristate
• sorbitan sesquioleate
• Macrogol glycerol hydroxystearate
• Hydrocarbons, microcrystalline
• 187 mg propylene glycol
• lactic acid

Indication/Application

• The preparation is a dermatic/keratolytic.
• The medicine is used to treat dry skin, e.g. B. in neurodermatitis or aging skin as well as for the supportive treatment of ichthyoses.

UREOTOP, urea ointment, reddening of the skin dosage

• Always use the medicine exactly as directed.
• Please check with your doctor or pharmacist if you are not sure.
• The usual dose is:
  • Unless otherwise prescribed, the ointment is applied once or twice a day to clean, dry skin and massaged in thoroughly until the symptoms subside. Airtight dressings according to the doctor's instructions.

• duration of use
  • No clinical data are available for use of the preparation for more than 3 weeks.
  • Please talk to your doctor or pharmacist if you have the impression that the effect of the medicine is too strong or too weak.

• If you use more than you should:
  • You can continue treatment with the indicated dosage. In the case of a short-term overdose, no impairments are to be expected.

• If you forgot the application:
  • Do not apply a double dose to make up for a forgotten application.

• If you cancel the application:
  • You could jeopardize the success of the treatment. Please talk to your doctor or pharmacist before stopping treatment with the preparation.

• If you have any further questions on the use of the medicine, ask your doctor or pharmacist.

UREOTOP, urea ointment, reddening of the skin way

• For application on the skin

side effects

• Like all medicines, the preparation can have side effects, but these do not necessarily occur in everyone treated. The evaluation of side effects is based on the following frequency information:
  • Very common: affects more than 1 in 10 people
  • Common: affects 1 to 10 users in 100
  • Uncommon: affects 1 to 10 users in 1,000
  • Rare: affects 1 to 10 users in 10,000
  • Very rare: affects less than 1 in 10,000 people
  • Not known: frequency cannot be estimated from the available data.
• possible side effects
  • Occasionally, allergic reactions to the ingredients can occur, as well as skin irritations such as burning, redness, itching or dandruff.
• special instructions
  • If a hypersensitivity reaction occurs, the drug should be discontinued and, if necessary, appropriate treatment should be administered by a doctor.
• If any of the side effects gets serious, or if you notice any side effects that are not listed, please tell your doctor or pharmacist.

UREOTOP, urea ointment, reddening of the skin interactions

• When using the preparation with other medicines:
  • Please inform your doctor or pharmacist if you are taking/using or have recently taken/used other medicines, even if they are non-prescription medicines.
  • The possibility of increased absorption of other externally applied substances (e.g. corticosteroids) should be taken into account in skin treated with urea.

Contraindications

• The drug must not be used
  • for the treatment of abraded, acute skin inflammation

pregnancy and breast feeding period

• Risks during pregnancy and lactation are not known. The drug should not be used in the breast area during breast-feeding.
• Ask your doctor or pharmacist for advice before taking/using any medicine.

patient UREOTOP, urea ointment, reddening of the skin notes

• Special care is required when using the drug:
  • Do not bring the ointment into contact with eyes or mucous membranes.
• children
  • There is no reliable experience with the use of the preparation in children.
  • Reports from the specialist literature indicate that the use of more concentrated urea-containing products in children can lead to mostly brief burning sensations on the skin.

• Driving and using machines
  • There is no experience of impairment of the ability to drive and use machines.